文献库搜索 | GeneLibs

Kelemen(I),Horti-Oravecz(K),Bozsik(A),Pócz... BMC Med 2026-08-25

...BRCA1 (gpath(BRCA1)) and in patients living with Lynch syndrome (LS). Pre-cancer women with gpath(BRCA1) exhibited an ac...

Hu(J),Lai(C),Wang(J),Yan(Z),Yuan(Z),Deng(C... Biomark Res 2026-08-28

...BRCA1, and TP53 were frequently recorded across trial-design and outcome-related fields. Future research should focus on...

Liu(W),Chen(S),Wang(L),Xiang(H),Tao(S) Front Immunol None

...BRCA1/RAD51 to replication foci to support viral replication without significantly compromising host HR repair. Upon vir...

Pektaş(S) Mol Biol Rep 2026-08-06

...BRCA1-derived peptide constructs were used to investigate how hydrophobic motif composition and sequence context influen...

Nash(A),Rouse(E),Firth(T),Dick(IM),Fear(VS... JTO Clin Res Rep 2026-10-00

...BRCA1-associated protein 1 (BAP1), a multifunctional tumour suppressor protein. Here, we aim to elucidate the effect of ...

Liu(Y),Sun(X),Liu(J) Front Oncol 2026-00-00

...BRCA1/2 testing showed no detectable mutation. After six cycles of albumin-bound paclitaxel plus carboplatin, ultrasound...

Palikhe(S),Qiao(L),Kutz(C),Liang(X),Dhoraj... Metabolism 2026-09-02

...BRCA1 mutation increases the risk of several cancers, including breast and ovarian cancer. While BRCA1 is best known for...

Deng(O),Nepomuceno(TDC),Fang(B),Welsh(EA),... PLoS One 2026-00-00

...BRCA1/2 are well-established biomarkers that predict sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPis). How...

Blanc-Durand(F),Rouleau(E),Pautier(P),Ngoi... J Gynecol Oncol 2026-01-00

...BRCA1 mutations and TERC amplification whereas LOH-low with low-grade endometrioid, MSI, ARID1A, PIK3CA, CTNNB1, and PTE...

Obeagu(EI),Okafor(CJ) Breast Cancer (Auckl) 2026-00-00

...BRCA1/2. ctDNA has demonstrated particular utility in identifying minimal residual disease, monitoring therapeutic respo...